Canine Mammary Tumours (CMTs) exploit Mitochondrial Cholesterol for aggressive reprogramming
L. Hardy, B. Kannan, M. Rigon, G. Benton-Hawthorn, R. L. Previdelli, I. M. Reichler, F. Guscetti, M. P. Kowalewski, M. Campanella
This study shows TSPO's role in aggressive canine mammary tumours by facilitating mitochondrial cholesterol handling, enhancing survival, and reducing Tamoxifen efficacy.
bioRxiv · Jun 23, 2024Cancer Biology